New Advances in Dyslipidemia | Buch | Englisch | 2024 | MDPI AG | EAN 9783036598
109,95 €
Dyslipidemia is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). However, despite current traditional therapies (e.g., statins), significant residual risks for the onset of ASCVD remain, warranting the need to better understand newer therapeutic options for diminishing this prospect.
Jetzt bei Ebay:
